Royalty Calculations. The royalties and allocation of Net Sales set forth in Subsection 4.01.01 above shall be in lieu of the royalties set forth in Section 3.05 hereof with respect to Net Sales of Licensed Products or Combination Products for the United States. Net Sales for the United States subject to royalty calculations pursuant to Subsection 4.01.01 shall also not be used in computing total annual Net Sales of Licensed Products and Combination Products pursuant to Section 3.
Appears in 3 contracts
Sources: Research, Development and License Agreement (Signal Pharmaceuticals Inc), Research, Development and License Agreement (Signal Pharmaceuticals Inc), Research, Development and License Agreement (Signal Pharmaceuticals Inc)